ImmunXperts: what changed
What changed
ImmunXperts
NACE 72.101, Research and development on biotechnology
filed annual accounts (NBB)
Net result for the year
-€3.0m
2023 · -€266,255-€2.7m
Equity
-€1.6m
2023 · €1.4m-€3.0m
Cash
€1.5m
2023 · €1.8m-€272,973
Balance sheet total
€9.6m
2023 · €10.8m-€1.3m
Largest movements
Assets
- Tangible fixed assets -€611,291
down €611,291 (-12.3%), from €5.0m to €4.4m
of which Assets under construction and advance payments: -€3.4m
- Cash -€272,973
down €272,973 (-15.3%), from €1.8m to €1.5m
mainly Net result for the year (-€3.0m) and Trade debts (-€870,998)
- Deferred charges and accrued income -€252,061
down €252,061 (-46.9%), from €537,123 to €285,062
- Receivables within one year -€197,324
down €197,324 (-11.9%), from €1.7m to €1.5m
of which Other amounts receivable: -€624,537
Equity and liabilities
- Profit (loss) carried forward -€3.0m
down €3.0m, from €461,534 to -€2.5m
- Other debts +€1.3m
up €1.3m (+17.5%), from €7.5m to €8.8m
- Short-term financial debts +€1.1m
new in 2024: €1.1m
- Trade debts -€870,998
down €870,998 (-64.6%), from €1.3m to €477,953
- Accrued charges and deferred income +€173,899
up €173,899, from €0 to €173,899
Income statement
- Gross operating margin -€2.2m
down €2.2m (-84.7%), from €2.6m to €393,338
- Depreciation +€327,619
up €327,619 (+58.5%), from €560,457 to €888,077
- Financial charges +€270,577
up €270,577 (+390%), from €69,316 to €339,893
- Staff costs -€126,209
down €126,209 (-5.5%), from €2.3m to €2.2m
- Financial income -€80,574
down €80,574 (-72.8%), from €110,640 to €30,066
Change in the result, 2023 to 2024
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2023
-€266,255
Gross operating margin
-€2.2m
Staff costs
+€126,209
Depreciation
-€327,619
Write-downs
+€31,530
Other operating charges
-€16,982
Financial income
-€80,574
Financial charges
-€270,577
Taxes
-€1,746
Result 2024
-€3.0m
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2023 and 2024 balance sheets and the 2024 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
-€1.1m
Investment
-€240,434
Financing
+€1.0m
Cash 2023
€1.8m
From operations (derived)
-€1.1m
Net result for the year
-€3.0m
Depreciation
+€888,077
Stocks and contracts
-€106,235
Receivables within one year
+€197,324
Deferred charges and accrued income
+€252,061
Trade debts
-€870,998
Tax, wage and social debts
+€65,766
Other debts
+€1.3m
Accrued charges and deferred income
+€173,899
Investment (derived)
-€240,434
Investment in fixed assets (net)
-€240,434
Financing
+€1.0m
Debts after one year
-€30,862
Current portion of long-term debt
-€10,290
Short-term financial debts
+€1.1m
Contributions, distributions and other
-€30,066
Cash 2024
€1.5m
brings cash intakes cash out
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €10,842,286 | €9,578,520 | -€1.3m | -11.7% |
| Fixed assets | 21/28 | €5,212,565 | €4,564,923 | -€647,643 | -12.4% |
| Intangible fixed assets | 21 | €128,551 | €101,930 | -€26,621 | -20.7% |
| Tangible fixed assets | 22/27 | €4,986,074 | €4,374,783 | -€611,291 | -12.3% |
| Plant, machinery and equipment | 23 | €1,327,637 | €1,129,797 | -€197,840 | -14.9% |
| Furniture and vehicles | 24 | €201,813 | €134,538 | -€67,274 | -33.3% |
| Leasing and similar rights | 25 | €60,887 | €29,548 | -€31,339 | -51.5% |
| Other tangible fixed assets | 26 | - | €3,080,899 | +€3.1m | |
| Assets under construction and advance payments | 27 | €3,395,737 | €0 | -€3.4m | -100% |
| Financial fixed assets | 28 | €97,940 | €88,210 | -€9,730 | -9.9% |
| Current assets | 29/58 | €5,629,720 | €5,013,597 | -€616,123 | -10.9% |
| Stocks and contracts in progress | 3 | €1,643,471 | €1,749,706 | +€106,235 | +6.5% |
| Stocks | 30/36 | €1,643,471 | €1,749,706 | +€106,235 | +6.5% |
| Amounts receivable within one year | 40/41 | €1,664,277 | €1,466,953 | -€197,324 | -11.9% |
| Trade receivables | 40 | €735,289 | €1,162,502 | +€427,213 | +58.1% |
| Other amounts receivable | 41 | €928,988 | €304,451 | -€624,537 | -67.2% |
| Cash at bank and in hand | 54/58 | €1,784,849 | €1,511,877 | -€272,973 | -15.3% |
| Deferred charges and accrued income | 490/1 | €537,123 | €285,062 | -€252,061 | -46.9% |
| Total equity and liabilities | 10/49 | €10,842,286 | €9,578,520 | -€1.3m | -11.7% |
| Equity | 10/15 | €1,403,965 | -€1,601,929 | -€3.0m | |
| Contributions | 10/11 | €830,879 | €830,879 | = | 0.0% |
| Capital | 10 | €830,879 | €830,879 | = | 0.0% |
| Issued capital | 100 | €830,879 | €830,879 | = | 0.0% |
| Reserves | 13 | €38,508 | €38,508 | = | 0.0% |
| Non-distributable reserves | 130/1 | €38,508 | €38,508 | = | 0.0% |
| Legal reserve | 130 | €38,508 | €38,508 | = | 0.0% |
| Profit (loss) carried forward | 14 | €461,534 | -€2,514,293 | -€3.0m | |
| Investment grants | 15 | €73,044 | €42,978 | -€30,066 | -41.2% |
| Amounts payable | 17/49 | €9,438,321 | €11,180,449 | +€1.7m | +18.5% |
| Amounts payable after more than one year | 17 | €32,385 | €1,522 | -€30,862 | -95.3% |
| Financial debts | 170/4 | €32,385 | €1,522 | -€30,862 | -95.3% |
| Amounts payable within one year | 42/48 | €9,405,936 | €11,005,028 | +€1.6m | +17.0% |
| Current portion of amounts payable after more than one year | 42 | €41,152 | €30,862 | -€10,290 | -25.0% |
| Financial debts | 43 | - | €1,109,156 | +€1.1m | |
| Credit institutions | 430/8 | - | €1,109,156 | +€1.1m | |
| Trade debts | 44 | €1,348,951 | €477,953 | -€870,998 | -64.6% |
| Suppliers | 440/4 | €1,348,951 | €477,953 | -€870,998 | -64.6% |
| Taxes, remuneration and social security | 45 | €562,318 | €628,084 | +€65,766 | +11.7% |
| Remuneration and social security | 454/9 | €562,318 | €628,084 | +€65,766 | +11.7% |
| Other amounts payable | 47/48 | €7,453,515 | €8,758,972 | +€1.3m | +17.5% |
| Accrued charges and deferred income | 492/3 | €0 | €173,899 | +€173,899 | |
| Non-recurring operating income | 76A | €11,940 | €0 | -€11,940 | -100% |
| Remuneration, social security and pensions | 62 | €2,292,329 | €2,166,120 | -€126,209 | -5.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €560,457 | €888,077 | +€327,619 | +58.5% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €15,765 | -€15,765 | -€31,530 | |
| Other operating charges | 640/8 | €1,252 | €18,234 | +€16,982 | +1,356% |
| Non-recurring operating charges | 66A | €0 | - | = | |
| Gross operating margin | 9900 | €2,563,153 | €393,338 | -€2.2m | -84.7% |
| Operating profit (loss) | 9901 | -€306,651 | -€2,663,328 | -€2.4m | -769% |
| Financial income | 75/76B | €110,640 | €30,066 | -€80,574 | -72.8% |
| Recurring financial income | 75 | €110,640 | €30,066 | -€80,574 | -72.8% |
| Financial charges | 65/66B | €69,316 | €339,893 | +€270,577 | +390% |
| Recurring financial charges | 65 | €69,316 | €339,893 | +€270,577 | +390% |
| Profit (loss) for the period before taxes | 9903 | -€265,328 | -€2,973,155 | -€2.7m | -1,021% |
| Income taxes | 67/77 | €927 | €2,673 | +€1,746 | +188% |
| Profit (loss) for the period | 9904 | -€266,255 | -€2,975,828 | -€2.7m | -1,018% |
| Profit (loss) for the period to be appropriated | 9905 | -€266,255 | -€2,975,828 | -€2.7m | -1,018% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.